Industries > Pharmaceutical/Biotech | SupplyChainBrain
Webinars
Podcasts
Videos
Events
Subscribe
Sign In
Logistics
Air Cargo
All Logistics
Facility Location Planning
Freight Forwarding/Customs Brokerage
Global Gateways
Global Logistics
Last Mile Delivery
Logistics Outsourcing
LTL/Truckload Services
Ocean Transportation
Parcel & Express
Rail & Intermodal
Reverse Logistics
Service Parts Management
Transportation & Distribution
Technology
All Technology
Artificial Intelligence
Cloud & On-Demand Systems
Data Management (Big Data/IoT/Blockchain)
ERP & Enterprise Systems
Forecasting & Demand Planning
Global Trade Management
Inventory Planning/Optimization
Product Lifecycle Management
Robotics
Sales & Operations Planning
SC Finance & Revenue Management
SC Planning & Optimization
Supply Chain Visibility
Transportation Management
General SCM
Business Strategy Alignment
Customer Relationship Management
Education & Professional Development
Global Supply Chain Management
Global Trade & Economics
Green Energy
HR & Labor Management
Quality & Metrics
Regulation & Compliance
Sourcing/Procurement/SRM
SC Security & Risk Mgmt
Supply Chains in Crisis
Sustainability & Corporate Social Responsibility
Warehousing
All Warehouse Services
Conveyors & Sortation
Lift Trucks & AGVs
Order Management & Fulfillment
Packaging
RFID, Barcode, Mobility & Voice
Warehouse Automation
Warehouse Management Systems
Industries
Aerospace & Defense
Apparel
Automotive
Chemicals & Energy
Consumer Packaged Goods
E-Commerce/Omni-Channel
Food & Beverage
Healthcare
High-Tech/Electronics
Industrial Manufacturing
Pharmaceutical/Biotech
Retail
Think Tank
Pharmaceutical/Biotech: Page 47
As Trade War Continues, Pharma Companies Prepare for Alternatives
The trade standoff between the U.S. and China has yet to seriously impact the pharmaceutical and life sciences industries. But as neither side shows signs of backing down, and tariffs continue to be levied on virtually every segment, those sectors are preparing for a major supply-chain disruption.
U.S., China Plan Opioid Bust That Could Help Trump Sell Trade Deal
China and the U.S. plan to highlight joint efforts to crack down on fentanyl smuggling, addressing an opioid epidemic that President Trump has asked his counterpart Xi Jinping to help alleviate as part of broader trade talks.
Global Drug Suppliers Challenge FDA as Safety Fears Rise
Regulators want to reduce U.S. dependence on foreign-made pharmaceutical ingredients, as a wave of recalls has raised questions about the safety of the global drug-supply chain.
China Drugmaking Giant Says Cheap Meds Stymie Pharma’s Future
China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers.
Drone Deliveries From Drugstore Now a Reality in Virginia Town
Alphabet Inc. offshoot Wing, which just received an expanded certification to act as a small air carrier, is starting the nation’s inaugural delivery service via a small civilian aircraft with partners Walgreens and FedEx.
U.K. Businesses’ Brexit Frustration Mounting With the Costs
While most business leaders want to avoid a no-deal departure, continued uncertainty is not much better. With the cliff edge looming, and the prospect of another one in three months if the EU grants Parliament’s request for a further delay, collateral damage is mounting.
Major U.S. Drugstore Chains Pull Zantac Amid Carcinogen Concern
The three major U.S. pharmacy chains are removing versions of the heartburn drug Zantac from store shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.
China’s Role as Global Drug Hub Raises Alarms in Washington
A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.
Beating Murphy's Law on Warehouse Automation Projects
Carcinogen in Zantac and Generics Triggers FDA, EU Probes
Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills.
Scenario Planning: How to Drive Better Decision Making in Integrated Business Planning
Get Rhythm: The Operating Cadence of Integrated Business Planning
Does your IBP process have rhythm or arrhythmia? Eric Deutsch and Timm Reiher answer questions they are frequently asked about the schedule and cadence of Integrated Business Planning (IBP). The topics covered include: The typical review meeting schedule The pre-tasks required to ensure effective reviews Is it okay to skip reviews What happens when reviews are combined The disadvantages of conducting IBP quarterly instead of monthly After reading this white paper, you will be able to assess the rhythm of your IBP process and whether improvements are needed. If your company is just starting to operate IBP, you will know the cadence pitfalls to avoid in designing the IBP process.
Previous Page
Page 47 of 336
Next Page
Sign me up!
Receive the latest supply chain trends, news and analysis from SupplyChainBrain.
Email Address
*
Sign Up
Featured Product
Case Studies
Case Studies
How a Leading U.S. Floral Distribution Company Reduced Warehouse Labor Costs by 45% with RFID
Case Studies
Recycled Tagging Fasteners: Small Changes Make a Big Impact
Case Studies
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Case Studies
Moving Robots Site-to-Site